Abiraterone acetate and apalutamide may provide the largest overall survival benefits for metastatic castration-sensitive prostate cancer with relatively low risk of serious adverse events. Enzalutamide may improve radiographic progression-free survival the most, but longer follow up is needed to fully examine its overall survival benefits. The study systematically reviewed randomized controlled trials comparing docetaxel, abiraterone acetate, apalutamide, and enzalutamide for metastatic castration-sensitive prostate cancer and found that abiraterone and apalutamide had the best balance of overall survival benefits and safety based on over 7,000 patients across multiple countries and regions.
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Comparing Metastatic Prostate Cancer Drugs
1. Presented by : Muhammad Zaky
Comparison of Systemic
Treatment for Metastatic
Castration-Sensitive Prostate
Cancer
Lin Wang, MD, MSc; Channing J. Paller, MD; Hwanhee Hong, PhD;
Anthony De Felice, MHS; G. Caleb Alexander, MD, MSc; Otis Brawley, MD
January 2021
Journal of the American Medical Association
2. Introduction
● The research compared effectiveness and safety about the drugs is limitless
PROSTATE CANCER
Is the most common cancer
among men in US
ADT for terapy mCSPC Combined with :
• Docetaxel
• Abiraterone
• Apalutamide
• Enzalutamide
mCRPC
3. Methods
• The interventions of interest : Docetaxel, Abiraterone Acetate, Apalutamide and
Enzalutamide
• The comparator of interest : Any Drug, Placebo or No Treatment
• Median follow up at least 12 months
ELIGIBILITY CRITERIA
EXCLUTION CRITERIA
Cluster design & dose
escalation trials
INCLUTION CRITERIA
RCTs of Parallel design for
mCSPC
4. Continue…
Bibliographic database (MEDLINE (PubMed Interface)
EMBASE (OVID interface)
The Cochrane Central Register of Controlled Trial (CENTRAL, Wiley interface)
Trial Registries (ClinicalTrials.gov and the EU Clinical Trials Register)
Regulatory Documents (US FDA and European Medicines Agency review
packets)
DATA SOURCES
5. Risk of Bias Assessment
● Using the Cochrane Collaboration tool
● Statistical Analysis : Bayesian network meta - analysis
10. CONCLUSIONS
Abiraterone acetate and Apalutamide may
provide the largest OS benefits with relatively
low SAE risk
Enzalutamide may improve rPFS to the
greatest extent, longer follow up is needed to
examine its OS benefits
12. Validity
1. Is the clinical
question clearly
focused with
regard to: PICO
Population?
YES
13. Validity
1. Is the clinical
question clearly
focused with
regard to: PICO
Intervention?
YES
14. Validity
1. Is the clinical
question clearly
focused with
regard to: PICO
Comparison?
YES
15. Validity
1. Is the clinical
question clearly
focused with
regard to:
Outcome?
YES
16. Validity
2. Are the criteria for
the selection of the
studies to be included
in the review in
accordance with:
● the specifications
of the foregoing
question in regard
to populations,
interventions and
results?
YES
17. Validity
2. Are the criteria for
the selection of the
studies to be included
in the review in
accordance with:
● the type of
research design
that will be
chosen?
YES
26. APPLICABILITY OF THE RESULTS
1. Are my patients similar to the patients included in the original studies? Yes (most
included trials were multinational, recruiting patients from America, Europe, Asia,
and Oceania)
2. Is the intervention feasible in my environment? Yes (the treatment is available in
Indonesia)
3. Do the benefits outweigh the potential harm and costs? Yes. It is explain side effect
of treatment. Which is more higher than other.
1. Table of contents
2. Introduction
3. Identifying information
4. Patient medical history
5. Review of systems
6. Physical examination
7. Big picture
8. Findings
9. Discussion
10. Discussion summary
11. Comparison
12. Diagnosis
13. Treatment
14. Patient monitoring
15. Contraindications and indications
16. Post-prevention
17. Case timeline
18. Conclusions
19. References
20. Our team
Parallel design RCT means subject are randomized to one or more study arms and each study arm will be allocated a different intervention
Dose escalation means sequentially administering increasing doses of an investigational drug or biologic to different cohorts of study subject until a highest dose that does not cause harmful side effect
Cluster design means groups or cluster of individual than individuals themselves are randomized
Bayesian network meta analysis is a method of statistical inference (named for English mathematician Thomas Bayes) that allows one to combine prior information about a population parameter with evidence from information contained in a sample to guide the statistical inference process.
The inverse of variance of hazard ratios of OS
Randomized controlled trials (RCT) are prospective studies that measure the effectiveness of a new intervention or treatment. Randomization reduces bias and provides a rigorous tool to examine cause-effect relationships between an intervention and outcome.
1. Table of contents
2. Introduction
3. Identifying information
4. Patient medical history
5. Review of systems
6. Physical examination
7. Big picture
8. Findings
9. Discussion
10. Discussion summary
11. Comparison
12. Diagnosis
13. Treatment
14. Patient monitoring
15. Contraindications and indications
16. Post-prevention
17. Case timeline
18. Conclusions
19. References
20. Our team